The World Vaccine Congress is now well-established as the must attend global vaccine event each year, where leaders of the industry come to discuss science and do business. Now in its 17th year, the event in 2017 will bring over 700 senior vaccine executives to learn, meet and form partnerships.
As always, the Congress will cover the crucial topics which are affecting the whole sector. From putting together a global strategy to respond to the next Zika virus , to exploring new vaccine technologies all from key KOLs from the WHO, FDA , big pharma and leading institutions .
Our agenda format also allows for whole-sector topics by running 8 parallel niche conferences over 2 days of the Congress, increasing the relevance of the whole event for everyone who attends.
Choose the sessions which are most applicable to help your business plan for the future of vaccine research, development and manufacture
The impact of this was to increase the quality of the speaker line-up and those who signed up to attend, as the content truly moved forward, covering the important blue-sky keynotes whilst also providing personalised content for every attendee.
In 2017, we will be building on this success to bring the community together for debate and discussion that is not available elsewhere, because of the quality of sessions you can participate in and the attendees who will be on-site.
Make sure you don’t miss out on the one event which facilitates the future of the vaccine industry.
Make sure you are at the forefront of the vaccines industry. No matter where your interest lies, we have content, networking and potential partners for you.
By bringing eight events together under one roof, you get to choose the sessions which are the most applicable to help your business plan for the future of vaccine research, development and manufacture.
Take just three days out of the office to meet with 700+ potential customers who need to find solutions to their challenges.
INFLUENZA AND RESPIRATORY
Find ways to improve development of universal influenza, RSV, MERS and Pneumococcal vaccines
BIOPROCESSING AND MANUFACTURING
Optimize early formulation through to clinical manufacturing, by embracing new techniques and technologies
CANCER AND IMMUNOTHERAPY
From new adjuvant technologies to novel immunotherapies, better understand the latest developments in the fast-evolving cancer landscape
Discuss how profiling of the immune system using high throughput technologies can aid therapeutic design and treatment strategies in infectious and noninfectious diseases including cancer
Hear from exciting new vaccine biotechs presenting on their pipeline as well as case studies and on how best to form public-private partnerships
EMERGING AND RE-EMERGING DISEASES
Understand the opportunities for your business in reacting to global threats like malaria, dengue and Ebola
Assess how to improve your clinical trial performance, from developing novel immunological assays to creating clinical efficacy
From livestock to companion, gain crucial insights into the emerging infections and new technologies changing the landscape